Skip to search formSkip to main contentSkip to account menu

Actilyse

Known as: Lysatec rt PA, Lysatec rt-PA, Lysatec rtPA 
National Institutes of Health

Related topics

Related topics

16 relations

Narrower (12)

BM 06.022D-K2PFb-Fb-CFKHRR 296-299 AAAA

Broader (3)

Fibrinolytic AgentsPlasminogen Activatoralteplase
Plasminogen activator tissue type:ACnc:Pt:PPP:Qn:Chromo

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Differentiation between dogs with thrombosis and normal dogs using the overall hemostasis potential assay.
OBJECTIVE To determine whether the overall hemostasis potential (OHP) and calibrated automated thrombogram (CAT) were… 
2014
2014
Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep.
2009
2009
Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC
We describe a case of inferior vena cava thrombosis (IVC) leading to bilateral renal vein thrombosis and renal failure in a… 
Review
2003
Review
2003
Good outcome in early pregnancy following direct thrombolysis for cerebral venous sinus thrombosis
Sirs: Cerebral sinus thrombosis (CVST) is more common in women and has been associated with pregnancy. However, there is very… 
2002
2002
Splanchnic extraction and clearance of tissue plasminogen activator (t-PA) after injection of recombinant t-PA (Actilyse®) in resting healthy subjects is proportional to the arterial concentration
The purpose of the study was to evaluate the splanchnic extraction of tissue plasminogen activator (t-PA) in normal healthy… 
1997
1997
Erfolge und Komplikationen der rTPA-Behandlung am vorderen Augenabschnitt
Recombinant tissue plasminogen activator (rTPA) is commonly used in patients with myocardial infarction. Recently, it has also… 
1996
1996
[Selective percutaneous transluminal thrombolytic therapy with rt-PA in central retinal artery occlusion].
UNLABELLED In central retinal arterial occlusion systemic fibrinolytic therapy can involve a variety of serious complications… 
1994
1994
Thrombolytic Treatment and Balloon Angioplasty in Chronic Occlusion of the Aortic Bifurcation
Complete occlusion of the subrenal aorta is usually initiated by arteriosclerotic lesions at the aortic bifurcation, including… 
Highly Cited
1993
Highly Cited
1993
Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.
OBJECTIVE--To determine the efficacy of fibrinolytic therapy with tissue plasminogen activator (alteplase) in infants and… 
1992
1992
Biochemical and Biological Properties of a Recombinant Tissue-Type Plasminogen Activator Derived from the Rat JMI-229 Cell Line
Summary Recombinant tissue-type plasminogen activator (rt-PA), produced by expression of the genomic t-PA DNA from the JMI-229… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)